🟢 MiniMed Group is trading 10% up today after earnings beat and raised guidance

MiniMed Group is trading at $22.30, up +10.07%, after an earnings beat and improved fiscal 2027 outlook.

• September 1, 2026 earnings showed $843 million in first-quarter revenue, with strong U.S. pump sales and MiniMed Flex adoption.
• Management raised fiscal 2027 organic revenue-growth guidance to approximately 10.5% from 10%, while maintaining its adjusted EBITDA-margin outlook near 16%.
• The gain came despite broader market weakness.